Tactile Systems Technology Inc (TCMD) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 16.00
(+67.71%)
Based on the Tactile Systems Technology Inc stock forecast from 2 analysts, the average analyst target price for Tactile Systems Technology Inc is USD 16.00 over the next 12 months. Tactile Systems Technology Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Tactile Systems Technology Inc is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Tactile Systems Technology Inc’s stock price was USD 9.54. Tactile Systems Technology Inc’s stock price has changed by -32.24% over the past week, -28.11% over the past month and -31.37% over the last year.
No recent analyst target price found for Tactile Systems Technology Inc
No recent average analyst rating found for Tactile Systems Technology Inc
Company Overview Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. Read Less
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; ...Read More
Frequently Asked Questions About Tactile Systems Technology Inc (TCMD) Stock
Based on ratings from 2 analysts Tactile Systems Technology Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Neutral. The stock has buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on TCMD's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for TCMD is USD 16.00 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 14.
TCMD stock's Price/Earning ratio is 20.83.
Our analysis grades TCMD stock's Price / Earning ratio at F. This means that TCMD stock's Price/Earning ratio is above 54% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this TCMD may be a overvalued for its sector.
The last closing price of TCMD's stock was USD 9.54.
The most recent market capitalization for TCMD is USD 0.35B.
Based on targets from 2 analysts, the average taret price for TCMD is projected at USD 16.00 over the next 12 months.
This means that TCMD's stock price may go up by +67.71% over the next 12 months.
We can't find any ETFs which contains Tactile Systems Technology Inc's stock.
As per our most recent records Tactile Systems Technology Inc has 1,037 Employees.
Tactile Systems Technology Inc's registered address is 3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416.
You can get more information about it from Tactile Systems Technology Inc's website at https://tactilemedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Tactile Systems Technology Inc (TCMD) Stock
Based on ratings from 2 analysts Tactile Systems Technology Inc's stock is Hold . Stock Target Advisor's fundamental analysis is Neutral. The stock has buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on TCMD's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for TCMD is USD 16.00 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 14.
TCMD stock's Price/Earning ratio is 20.83.
Our analysis grades TCMD stock's Price / Earning ratio at F. This means that TCMD stock's Price/Earning ratio is above 54% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this TCMD may be a overvalued for its sector.
The last closing price of TCMD's stock was USD 9.54.
The most recent market capitalization for TCMD is USD 0.35B.
Based on targets from 2 analysts, the average taret price for TCMD is projected at USD 16.00 over the next 12 months.
This means that TCMD's stock price may go up by +67.71% over the next 12 months.
We can't find any ETFs which contains Tactile Systems Technology Inc's stock.
As per our most recent records Tactile Systems Technology Inc has 1,037 Employees.
Tactile Systems Technology Inc's registered address is 3701 Wayzata Boulevard, Minneapolis, MN, United States, 55416.
You can get more information about it from Tactile Systems Technology Inc's website at https://tactilemedical.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TCMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
